Page results
-
This information is for patients who are having radiotherapy to the pelvis.
-
Our andrology unit manages patients with andrological conditions including male sterilisation and infertility service, and other disorders of the penis or male genitalia.
-
Preparations for the festive season are in full swing in the UCLH Charity fundraising team.
-
Dr Swayne is a consultant neurologist with a special interest in neurorehabilitation and stroke.
-
Advice for University College London Hospital patients who have experienced hair loss.
-
This patient information offers advice for patients suffering from long COVID regarding a healthy diet and nutrition.
-
Diet and nutrition advice for people experiencing weight loss, weight gain, appetite changes, difficulty eating, or other digestive problems which have happened as a result of their treatment or condition. Advice is also available for people who are confused about what diet or nutrition advice to follow.
-
The flow cytometry laboratory provides a Haematological Malignancy diagnostic service which includes chronic and acute leukaemias and lymphomas.
-
The Interventional Oncology Service (IOS) at University College London Hospital (UCLH) is committed to improving the experience and outcomes for patients with cancer through cutting edge image guided interventions.
-
This page is for patients having planned neurosurgery.
File results
-
FOI/2023/0109 - UK-EU aggrement S2 funding applications and treatments
-
FOI/2023/0110 - General anaesthesia paediatric dental waiting times
-
FOI/2023/0111 - Migraine treatment
-
FOI/2023/0114 - Electronic Patient Record/ Electronic Health Record systems
-
FOI/2023/0115 - Deaths in A&E
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0126 - Repayment fees for internationally recruited nurses
-
FOI/2023/0103 - Genetic Haemochromatosis patients
-
FOI/2023/0122 - Usage of Pembrolizumab for the treatment of melanoma